These findings contribute to our understanding of the IGF2BP3/OIP5-AS1/Trim21/hnRNPA1/PKM2 axis in GC and suggest that OIP5-AS1 may open a potential novel perspective for diagnostic and therapeutic regimens in GC. This evidence concerns the gene OIP5 and gastric cancer.